Doxazosin Tablet
Product Images NDC 68071-4892

This is a description of a medication called Doxazosin, available in the form of capsule-shaped light pink tablets scored on one side, with the code "785" on one side and "E" on the other side, containing 4mg of Doxazosin, which is equivalent to 4.852mg of Doxazosin Mesylate, USP. The medication is distributed by NuCare Pharmaceuticals, Inc. and is available by prescription only. The lot number is 000000, and the manufacturer's National Drug Code (NDC) is 68382-785-01, while the product NDC is 68071-4892-9. The medication comes in a bottle of 90 tablets, and the recommended dosage is three tablets per day. It is essential to store this medication at a controlled temperature of 68-77°F and keep out of reach of children. Individuals should seek medical advice about any side effects, and side effects may be reported to the FDA at 1-800-FDA-1088.*

This text describes the results of three studies conducted to evaluate the effectiveness of Dorazosin, a medication used to treat hypertension and benign prostatic hyperplasia. The studies measured symptom scores and rates of maximum flow. Study 1 titrated the dose to a maximum of 8 mg, study 2 titrated to a fixed dose for 14 weeks, and study 3 titrated to a fixed dose for 12 weeks. The placebo group had lower scores and rates compared to the Dorazosin groups across all studies. The AUA questionnaire was used for studies 1 and 3, and the Modified Boyarsky Questionnaire was used for study 2. The study had 36 patients who received a dose of 8mg Dorazosin, and the results showed significant improvement compared to the placebo group (p<006 (001)).*